Exchange:
Industry: Pharmaceuticals & Biotechnology
Last Trade: 3:59 PM ET 5/24/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.00 | 0.00 | 0.00 |
| EPS, GAAP | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 0.00 | 0.00 | 0.00 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 0.00 | 0.00 | 0.00 |
| EPS, GAAP | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 0.00 | 0.00 | 0.00 |
| RHHBY | Industry Average | |
| P/E (TTM) | 0.00 | NA |
| P/E (Forward) | 0.00 | NA |
| PEG Ratio | 0.00 | 0.00 |
| Price/Sales | 0.00 | 0.00 |
| Beta | 0.00 | 0.00 |
| 6:23 AM | 5/22/2012 | Roche Drugs To Be Key Focus At Upcoming US Cancer Meeting ASCO |
| 7:15 PM | 5/9/2012 | UK Health Watchdog Backs Lung Cancer Drug From Roche |
| 5/21/2012 | BofA Merrill Names New Healthcare Banking Head (WSJ.com) |
| 5/18/2012 | Europe stocks fall after Spain bank downgrades (MarketWatch.com) |
| 5/9/2012 | Deals of the Day: Glaxo Goes Hostile for Human Genome (WSJ.com) |
| 5/8/2012 | Europe stocks tumble amid Greek political concerns (MarketWatch.com) |
| 5/3/2012 | Europe stocks rise ahead of ECB meeting (MarketWatch.com) |
| 4/20/2012 | The Winners & Losers From the Week That Was (WSJ.com) |
| 4/20/2012 | Dealpolitik: Is Human Genome Sciences Trying to 'Roche' Glaxo? (WSJ.com) |
| 4/19/2012 | Gilead Soars on Promising Hepatitis C Drug Results (Barrons.com) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)
